State and Local Estimates of the Uninsured Population in the U.S. Using the Census Bureau’s 2022 American Community SurveyMethodological Description
Race & Ethnicity
Reports
Displaying 11 - 20 of 119. 10 per page. Page 2.
Advanced SearchDatabase, Dataset
State and Local Estimates of the Uninsured Population in the U.S. Using the Census Bureau’s 2022 American Community Survey
ASPE Issue Brief
Substance Use and SUDs by Race and Ethnicity
This brief assesses whether and how rates of substance use and substance use disorder (SUD) among adults (ages 18 and older) differ by race and ethnicity. The authors combine five years of data, 2015-2019, from the National Survey on Drug Use and Health (NSDUH) to create sample sizes large enough to examine specific racial and ethnic groups for specific categories of drug use.
Policy Brief
Refugee and Asylee Data on the Utilization of Medicaid
This brief describes a joint project of the ASPE and the Office of Refugee Resettlement in the Administration for Children and Families to enhance the data infrastructure of agencies managing refugees and Medicaid services. This project is funded by the Patient-Centered Outcomes Research Trust Fund.
Report
Linking State Medicaid Data and Birth Certificates For Maternal Health Research
This report presents the set of guiding principles for linking state Medicaid data with birth certificates that was developed by state and national experts and leaders. These guiding principles can be implemented to create a multistate linked database that researchers would be able to access and use for research on maternal health, including patient-centered outcomes research (PCOR).
Fact Sheet
Inflation Reduction Act Research Series: Projected Impacts for Asian, Black, and Latino Medicare Enrollees
The Inflation Reduction Act (IRA) is helping people with Medicare afford their medications, including the 2.1 million Asian, 5.8 million Black, and 5.3 million Latino Part D enrollees. These fact sheets review existing research to present the projected impacts of key IRA Medicare drug-related provisions for these populations.
Environmental Scan, Report
Best Practices for COVID-19 Vaccination and Testing
The Office of the Assistant Secretary for Planning and Evaluation (ASPE) released an environmental scan report that tells the emerging story of the many successes and challenges in improving COVID-19 testing and vaccination rates, especially among people who are medically or socially at disproportionate risk of COVID-19 or related adverse outcomes.
Fact Sheet, Report
Inflation Reduction Act Research Series: Understanding Development and Trends in Utilization and Spending for Drugs Selected Under the Medicare Drug Price Negotiation Program
The Inflation Reduction Act (IRA) authorizes the Secretary of the Department of Health and Human Services (HHS) to negotiate prices directly with participating manufacturers for selected drugs that are high expenditure, single source drugs without generic or biosimilar competition.
ASPE Issue Brief
Caregivers and Long-Term Services and Supports
As the United States population ages, a larger proportion of individuals will likely need and use long-term services and supports (LTSS). Much of this support is provided by informal (i.e., unpaid) caregivers. For those that need paid LTSS, most Americans pay out-of-pocket. Some may do so until their personal resources are exhausted, and then rely on the Medicaid safety net.
Report
Updated Medicare FFS Telehealth Trends by Beneficiary Characteristics, Visit Specialty and State, 2019-2021
This research report updates prior reports on Medicare FFS telehealth trends during the COVID-19 public health emergency with data through end of 2021, by beneficiary characteristics, visit specialty and geography including by state. Medicare telehealth flexibilities during the COVID-19 pandemic continued to encourage use of telehealth among Medicare beneficiaries in 2021.
Report
Inflation Reduction Act Research Series: Medicare Part D Enrollee Out-of-Pocket Spending: Recent Trends and Projected Impacts of the Inflation Reduction Act
The Inflation Reduction Act (IRA) will make key changes to improve drug affordability for people who have Medicare.